临床心身疾病杂志
臨床心身疾病雜誌
림상심신질병잡지
JOURNAL OF CLINICAL PSYCHOSOMATIC DISEASES
2014年
2期
38-39,48
,共3页
失眠症%佐匹克隆%奥沙西泮%睡眠障碍评定量表%副反应量表
失眠癥%佐匹剋隆%奧沙西泮%睡眠障礙評定量錶%副反應量錶
실면증%좌필극륭%오사서반%수면장애평정량표%부반응량표
Insomnia%zopiclone%oxazepam%SDRS%TESS
目的:探讨佐匹克隆与奥沙西泮治疗失眠症患者的临床疗效和安全性。方法将100例失眠症患者随机分为研究组51例,对照组49例,研究组口服佐匹克隆治疗,对照组口服奥沙西泮治疗,观察4周。于治疗前后采用睡眠障碍评定量表评定临床疗效,副反应量表评定不良反应。结果治疗4周末,研究组显效率86.3%、总有效率96.1%,对照组分别为77.6%、93.9%,两组临床疗效比较差异无显著性(χ2=1.31,P>0.05)。研究组不良反应发生率为9.8%,对照组为42.8%,研究组显著低于对照组(χ2=14.19,P<0.01)。结论佐匹克隆与奥沙西泮治疗失眠症疗效显著,总体疗效相当,但佐匹克隆安全性更高,依从性更好,更适用于初次就诊的失眠症患者。
目的:探討佐匹剋隆與奧沙西泮治療失眠癥患者的臨床療效和安全性。方法將100例失眠癥患者隨機分為研究組51例,對照組49例,研究組口服佐匹剋隆治療,對照組口服奧沙西泮治療,觀察4週。于治療前後採用睡眠障礙評定量錶評定臨床療效,副反應量錶評定不良反應。結果治療4週末,研究組顯效率86.3%、總有效率96.1%,對照組分彆為77.6%、93.9%,兩組臨床療效比較差異無顯著性(χ2=1.31,P>0.05)。研究組不良反應髮生率為9.8%,對照組為42.8%,研究組顯著低于對照組(χ2=14.19,P<0.01)。結論佐匹剋隆與奧沙西泮治療失眠癥療效顯著,總體療效相噹,但佐匹剋隆安全性更高,依從性更好,更適用于初次就診的失眠癥患者。
목적:탐토좌필극륭여오사서반치료실면증환자적림상료효화안전성。방법장100례실면증환자수궤분위연구조51례,대조조49례,연구조구복좌필극륭치료,대조조구복오사서반치료,관찰4주。우치료전후채용수면장애평정량표평정림상료효,부반응량표평정불량반응。결과치료4주말,연구조현효솔86.3%、총유효솔96.1%,대조조분별위77.6%、93.9%,량조림상료효비교차이무현저성(χ2=1.31,P>0.05)。연구조불량반응발생솔위9.8%,대조조위42.8%,연구조현저저우대조조(χ2=14.19,P<0.01)。결론좌필극륭여오사서반치료실면증료효현저,총체료효상당,단좌필극륭안전성경고,의종성경호,경괄용우초차취진적실면증환자。
Objective To explore the efficacy and safety of zopiclone and oxazepam in the treatment of in-somnia .Methods A total of 100 insomnia patients were randomly divided into research (n=51) and con-trol group (n=49) ,research took orally zopiclone and control group did oxazepam for 4 weeks .Efficacies were assessed with the Sleep Dysfuntion Rating Scale (SDRS) before and after treatment and adverse reac-tions with the Treatment Emergent Symptom Scale (TESS) .Results At the end of the 4th week obvious and total effective rate were respectively 86 .3% and 96 .15 in research and 77 .6% and 93 .9% in control group ,which showed no significant differences (χ2 =1 .31 ,P>0 .05) .The rate of adverse reactions was 9 . 8% in research and 42 .8% in control group ,the former was significantly lower than the latter (χ2 =14 .19 ,P<0 .01) .Conclusion Both zopiclone and oxazepam have an evident and equivalent effect in in-somnia ,but the former has higher safety and better compliance and is more suitable for first-visiting in-somnia patients .